Volume 28, Number 10—October 2022
Research Letter
Cluster of Donor-Derived Cryptococcosis after Liver and Kidney Transplantation
Table
Postoperative cryptococcal antigen titer change and antifungal treatment regimen for transplant donor in cluster of donor-derived cryptococcosis, China
| Postoperative day | Cryptococcal antigen titer | Treatment |
|---|---|---|
| 30 | >1:2,560 | Amphotericin B lipid complex and 5‐flucytosine |
| 60 | >1:1,280 | Oral fluconazole, 400 mg/d |
| 90 | >1:640 | Oral fluconazole, 400 mg/d |
| 120 | 1:640 | Oral fluconazole, 400 mg/d |
| 180 | 1:128 | Oral fluconazole, 400 mg/d |
| 270 | 1:128 | Oral fluconazole, 400 mg/d |
| 360 | 1:32 | Oral fluconazole, 400 mg/d |
| 450 | Negative result | Discontinued |
1These authors contributed equally to this article.
Page created: July 31, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.